MARKET INTRODUCTION
Tuberculosis (TB) treatment is completed over a long period, and constant medicine and monitoring is needed during the treatment. This eventually results in complete high treatment costs. Increasing prevalence of pediatric tuberculosis and growing incidence of multi-drug-resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR) TB incidences are more driving the growth of the market.
MARKET DYNAMICS
The anti-tuberculosis therapeutics market is projected to grow in the forecast period owing to growing prevalence of tuberculosis, rising government initiative for tuberculosis awareness, increasing healthcare expenditure and developed diagnostic strategies. Moreover, the upsurge in number of hospitals and clinics for TB is also offering opportunities in market growth during the forecast period.
MARKET SCOPE
The "Global Anti-Tuberculosis Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-tuberculosis therapeutics market with detailed market segmentation by drug class, end user and geography. The global anti-tuberculosis therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anti-tuberculosis therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global anti-tuberculosis therapeutics market is segmented on the basis of drug class and end user. Based on drug class, the market is segmented into isoniazid, rifampin, ethambutol, pyrazinamide, fluoroquinolones, aminoglycosides, and others. Based on end user, the anti-tuberculosis therapeutics market is segmented into hospitals & clinics, government agencies, non profit organizations, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anti-tuberculosis therapeutics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-tuberculosis therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti-tuberculosis therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-tuberculosis therapeutics market in these regions.

MARKET PLAYERS
The report covers key developments in the Anti-tuberculosis therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anti-tuberculosis therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Anti-tuberculosis therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Anti-tuberculosis therapeutics market.
The report also includes the profiles of key Anti-tuberculosis therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Macleods Pharmaceuticals Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- LUPIN
- Novartis AG
- AstraZeneca PLC
- Eli Lilly And Company
- GlaxoSmithKline Plc.
- Sanofi
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.